Mark Cuban Cost Plus Drug and Expion Health Partner to Transform Pharmacy Costs Together

Expion Health, renowned for its innovative technology and pricing strategies, has announced a groundbreaking collaboration with Mark Cuban Cost Plus Drug Company, PBC. This strategic partnership will integrate Cost Plus Drugs' revolutionary pricing model into Expion Health's product suite, offering a unique solution to address the rising costs of specialty drugs.

Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, expressed excitement about the collaboration, emphasizing the shared commitment to delivering lower prescription drug prices. He highlighted the convenience of medication delivery to consumers' homes, ensuring they receive fair and affordable pricing.